Comparison of causes of stillbirth and child deaths as determined by verbal autopsy and minimally invasive tissue sampling.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2024
Historique:
received: 29 03 2024
accepted: 02 07 2024
medline: 29 7 2024
pubmed: 29 7 2024
entrez: 29 7 2024
Statut: epublish

Résumé

In resource-limited settings where vital registration and medical death certificates are unavailable or incomplete, verbal autopsy (VA) is often used to attribute causes of death (CoD) and prioritize resource allocation and interventions. We aimed to determine the CoD concordance between InterVA and CHAMPS's method. The causes of death (CoDs) of children <5 were determined by two methods using data from seven low- and middle-income countries (LMICs) enrolled in the Child Health and Mortality Prevention Surveillance (CHAMPS) network. The first CoD method was from the DeCoDe panel using data from Minimally Invasive Tissue Sampling (MITS), whereas the second method used Verbal Autopsy (VA), which utilizes the InterVA software. This analysis evaluated the agreement between the two using Lin's concordance correlation coefficient. The overall concordance of InterVA4 and DeCoDe in assigning causes of death across surveillance sites, age groups, and causes of death was poor (0.75 with 95% CI: 0.73-0.76) and lacked precision. We found substantial differences in agreement by surveillance site, with Mali showing the lowest and Mozambique and Ethiopia the highest concordance. The InterVA4 assigned CoD agrees poorly in assigning causes of death for U5s and stillbirths. Because VA methods are relatively easy to implement, such systems could be more useful if algorithms were improved to more accurately reflect causes of death, for example, by calibrating algorithms to information from programs that used detailed diagnostic testing to improve the accuracy of COD determination.

Identifiants

pubmed: 39074089
doi: 10.1371/journal.pgph.0003065
pii: PGPH-D-24-00411
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0003065

Informations de copyright

Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Nega Assefa (N)

College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Anthony Scott (A)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Lola Madrid (L)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Merga Dheresa (M)

College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Gezahegn Mengesha (G)

College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Shabir Mahdi (S)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Sana Mahtab (S)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Ziyaad Dangor (Z)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Nellie Myburgh (N)

Centre pour le Développement des Vaccins), Ministère de la Santé, Bamako, Mali.

Lesego Kamogelo Mothibi (LK)

Centre pour le Développement des Vaccins), Ministère de la Santé, Bamako, Mali.

Samba O Sow (SO)

Centre pour le Développement des Vaccins), Ministère de la Santé, Bamako, Mali.

Karen L Kotloff (KL)

Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

Milagritos D Tapia (MD)

Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

Uma U Onwuchekwa (UU)

Centre pour le Développement des Vaccins), Ministère de la Santé, Bamako, Mali.

Mahamane Djiteye (M)

Centre pour le Développement des Vaccins), Ministère de la Santé, Bamako, Mali.

Rosauro Varo (R)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.

Inacio Mandomando (I)

Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Instituto Nacional de Saude, Ministerio de Saude, Maputo, Mozambique.

Ariel Nhacolo (A)

Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.

Charfudin Sacoor (C)

Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.

Elisio Xerinda (E)

Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.

Ikechukwu Ogbuanu (I)

Crown Agents, Freetown, Sierra Leone.

Solomon Samura (S)

World hope international, Makeni, Sierra Leone.

Babatunde Duduyemi (B)

University of Sierra Leone Teaching Hospitals Complex, Sierra Leone.

Alim Swaray-Deen (A)

University of Ghana Medical School, Accra, Ghana.

Abdulai Bah (A)

FOCUS 10000, Freetown, Sierra Leone.

Shams El Arifeen (S)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh.

Emily S Gurley (ES)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.

Mohammed Zahid Hossain (MZ)

International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh.

Afruna Rahman (A)

Program for Emerging Infections, Infectious Disease Division, International Centre for Diarrhoeal Disease Research Bangladesh b, Dhaka, Bangladesh.

Atique Iqbal Chowdhury (AI)

International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh.

Bassat Quique (B)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Instituto Nacional de Saude, Ministerio de Saude, Maputo, Mozambique.

Portia Mutevedzi (P)

Global Health Institute, Emory University, Atlanta, Georgia, United States of America.

Solveig A Cunningham (SA)

Global Health Center, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Dianna Blau (D)

Global Health Center, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Cyndy Whitney (C)

Global Health Institute, Emory University, Atlanta, Georgia, United States of America.

Classifications MeSH